Who owns REVIV3 PROCARE CO?
- Ticker: AXIL
- CUSIP Number: 76151r206
Tip: Access positions for across all investors
Analyze quarterly positions in Reviv3 Procare with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Reviv3 Procare stock
Who bought or sold REVIV3 PROCARE CO this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Private Advisory | 335k | $2.3M | 0% | Mar 2026 |
|
| Diversify Wealth Management | 187k | $1.3M | -14% | Mar 2026 |
|
| Soltis Investment Advisors | 180k | $1.3M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 60k | $418k | 100% | Mar 2026 |
|
| Vanguard Group | 55k | $381k | 0% | Dec 2025 |
|
| FNY Investment Advisers | 40k | $278k | 88% | Mar 2026 |
|
| Wells Fargo & Company | 40k | $278k | 0% | Mar 2026 |
|
| Geode Capital Management | 38k | $268k | 16% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 20k | $138k | 100% | Mar 2026 |
|
| Cetera Investment Advisers | 13k | $91k | -19% | Mar 2026 |
|
| State Street Corporation | 13k | $88k | 100% | Dec 2025 |
|
| BlackRock | 10k | $71k | 13% | Mar 2026 |
|
| Glass Jacobson Investment Advisors | 2.5k | $18k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 273.00 | $2.0k | 100% | Mar 2026 |
|
| Tower Research Capital | 154.00 | $1.1k | 100% | Dec 2025 |
|
| UBS Group | 20.00 | $140.000000 | -98% | Mar 2026 |
|
Who sold out of Reviv3 Procare?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wellington Grp | Dec 2025 | 2.2k | $15k |
| Jones Financial Companies, L.L | Sep 2025 | 350.00 | $2.0k |